Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-04 Sale |
2024-01-05 6:26 pm |
Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel |
10,676 | $1.1836 | $12,636 | 928,966 (Direct) |
View |
| 2020-10-14 Purchase |
2020-10-16 3:40 pm |
Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel |
5,250 | $19 | $99,750 | 614,600 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-24 Option Award |
2024-05-24 6:58 pm |
N/A 2034-05-23 |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2024-05-15 Option Award |
2024-05-17 4:30 pm |
N/A 2034-05-15 |
XOMA Corp | XOMA | Kosacz Barbara Director |
9,763 | $0 | 9,763 (Direct) |
View |
| 2024-02-14 Other |
2024-02-16 7:40 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Kosacz Barbara Director |
5,828 | $0 | 11,656 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 6:06 pm |
N/A 2033-05-18 |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:30 pm |
N/A 2033-05-17 |
XOMA Corp | XOMA | Kosacz Barbara Director |
10,967 | $0 | 10,967 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:19 pm |
N/A 2033-02-14 |
Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel |
347,278 | $0 | 1,148,009 (Direct) |
View |
| 2022-07-25 Option Award |
2022-07-27 6:18 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel |
53,600 | $0 | 791,624 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-27 5:47 pm |
N/A 2032-05-19 |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
13,871 | $0 | 13,871 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 09:00 am |
N/A 2032-05-18 |
XOMA Corp | XOMA | Kosacz Barbara Director |
8,996 | $0 | 8,996 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:23 pm |
N/A 2032-02-14 |
Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel |
133,600 | $0 | 818,024 (Direct) |
View |
| 2021-10-08 Other |
2021-10-12 7:24 pm |
N/A N/A |
PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Kosacz Barbara Director |
17,500 | $0 | 17,500 (Indirect) |
View |
| 2021-05-19 Option Award |
2021-05-21 4:30 pm |
N/A 2031-05-19 |
XOMA Corp | XOMA | Kosacz Barbara Director |
5,101 | $0 | 5,101 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:38 pm |
N/A 2031-03-03 |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
27,742 | $0 | 27,742 (Direct) |
View |
Ownership |
2021-03-08 4:29 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
0 | $0 | 0 (Direct) |
View |
| 2021-01-12 Other |
2021-01-14 7:50 pm |
N/A N/A |
Locust Walk Acquisition Corp. | LWAC | Kosacz Barbara Director |
17,500 | $0 | 17,500 (Indirect) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:35 pm |
N/A 2030-12-08 |
Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel |
174,560 | $0 | 789,160 (Direct) |
View |
Ownership |
2020-10-08 7:06 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel |
0 | $0 | 609,350 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-27 2:30 pm |
N/A 2030-05-20 |
XOMA Corp | XOMA | Kosacz Barbara Director |
6,152 | $0 | 6,152 (Direct) |
View |